Darbepoetin alpha ameliorates neuronal damage in a rat model of acute ethanol intoxication

International Journal of Neuroscience

Volumn 123, Issue 2, 2012, Pages 99-103

  Seymen, Pinar ^a   Aytac, Erman ^b   Esen, Fehim ^c   Tel, Cigdem ^b   Demir, Fatih ^b   Genc, Habibe ^b   Uzun, Hafize ^b   Oz, Buge ^b   Altug, Tuncay ^b   Seymen, Hakki Oktay ^b  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Alcohol; Darbepoetin alpha; Neurodegeneration; Neuron specific enolase; S100

Indexed keywords

ALCOHOL; NEURON SPECIFIC ENOLASE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN S 100;

ALCOHOL INTOXICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DENTATE GYRUS; HISTOPATHOLOGY; IN VIVO STUDY; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; RAT;

EID: 84872745790     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.738732     Document Type: Article

References (24)

1. Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS. Binge drinking among US adults. JAMA. 2003;289:70-5. (Pubitemid 36026280)
2. Chikritzhs TN, Jonas HA, Stockwell TR, Heale PF, Dietze PM. Mortality and life-years lost due to alcohol: A comparison of acute and chronic causes. Med J Aust. 2001;174:281-84. (Pubitemid 32509617)
3. Masalkar PD, Abhang SA. Oxidative stress and antioxidant status in patients with alcoholic liver disease. Clin Chim Acta. 2005;355:61-5.
4. Ward RJ, Lallemand F, de Witte P. Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse. Alcohol. 2009:44(2):128-35.
5. Seymen P, Aytac E, Bolukbasi F, Demir F, Genc H, Uzun H, Altug T, Seymen HO. Effect of darbepoetin alpha on brain tissue oxidative stress in experimental ethanoladministration. Trakya Univ Tip Fak Derg. 2009:26(2):95-9.
6. Upadhya SC, Tirumalai PS, Boyd MR, Ravindranath V. Cytochrome P4502E (CYP2E) in brain constitutive expression, induction by ethanol and localization by fluorescence in situ hybridisation. Arch Biochem Biophys. 2000;373:23-34. (Pubitemid 30046486)
7. Peters TJ, Ward RJ. Role of acetaldehyde in the pathogenesis of alcoholic. Mol Aspects Med. 1988;10:179-90.
8. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade ofNMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283:70-4. (Pubitemid 29044848)
9. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269-95. (Pubitemid 17022775)
10. Mussack T, Biberthale P, Kanz KG, Heckl U. Immediate S-100b and neuron-Specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock. 2002:18(5):395-400.
11. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg. 1999;13:56-9. (Pubitemid 29139950)
12. Rasmussen LS, Christiansen M, Hansen PB, Moller JT. Do blood levels of neuron specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass? Acta Anaesthesiol Scand. 1999;43:495-500. (Pubitemid 29232715)
13. Rasmussen LS, Poulsen MG, Christiansen M, Jansen EC. Biochemical markers for brain damage after carbon monoxide poisoning. Acta Anaesthesiol Scand. 2004;48:469-73. (Pubitemid 38523555)
14. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care. 2008;14:135-41. (Pubitemid 351498777)
15. Kumral A, Tugyan K, Gonenc S, Genc K, Genc S, Sonmez U, Yilmaz O, Duman N. Protective effects of erythropoietin against ethanol-induced apoptotic neurodegeneration and oxidative stress in the developing C57BL/6 mouse brain. Dev Brain Res. 2005;160:146-56. (Pubitemid 41735121)
16. Jelkmann W. Molecular biology of erythropoietin. Int Med. 2004;43:649-59. (Pubitemid 39264162)
17. Belayev L, Khoutorova L, Zhao W, Vigdorchik A, Belayev A, Busto R, Magal E, Ginsberg MD. Neuroprotective effect of darbepoetin alpha, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke. 2005;36:1071-76.
18. MutchWAC,GrahamMR, Halliday WC, Teskey JM, Thomson IR. Paraplegia following thoracic aortic cross-Clamping in dogs: No difference in neurological outcome with a barbiturate versus isoflurane. Stroke. 1993;24:1554-60. (Pubitemid 23285211)
19. Auer RN, Olsson Y, Siesjo BK. Hypoglycemic brain injury in the rat: Correlation of density of brain damage with the EEG isoelectric time: A quantitative study. Diabetes. 1984;33:1090-98. (Pubitemid 15204588)
20. Wang J, Tsirka SE. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain. 2005;128:1622-33. (Pubitemid 41373681)
21. Xue M, Fan Y, Liu S, Zygun DA, Demchuk A, Yong VW. Contributions of multiple proteases to neurotoxicity in a mousemodel of intracerebral haemorrhage. Brain. 2009;132(Pt 1):26-36.
22. Kanellakis P, Pomilio G, Agrotis A, Gao X, Du XJ, Curtis D, Bobik A. Darbepoetin-Mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-Common beta-Chain heteroreceptor. Br J Pharmacol. 2010;160(8):2085-96.
23. Ehrenreich H. Medicine A boost for translational neuroscience. Science. 2004;305:184-85.
24. Mao W, Iwai C, Liu J, Sheu SS, Fu M, Liang CS. Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways. J Mol Cell Cardiol. 2008;45:250-60.